Please login to the form below

Not currently logged in
Email:
Password:

sexual dysfunction

This page shows the latest sexual dysfunction news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Sprout Pharma's 'female Viagra'

FDA panel backs Sprout Pharma's 'female Viagra'

The panel voted by 18 to 6 that the drug - called flibanserin - should be approved to treat hypoactive sexual desire disorder (HSDD) in pre-menopausal women, opening the door for a ... However, the committee said that given the intended use of the drug

Latest news

  • Lundbeck launches Brintellix in first EU market Lundbeck launches Brintellix in first EU market

    Clinical trial results suggest Brintellix is at least as effective as Lexapro in adult patients with major depressive disorders and is significantly less likely to cause sexual dysfunction, a common problem

  • Menarini to raise awareness of sexual dysfunction Menarini to raise awareness of sexual dysfunction

    The rugby player ambassadors of Menarini's sexual dysfunction campaign. Italian pharma company A. ... Menarini Farmaceutica Internazionale has launched a campaign to address poor awareness of sexual dysfunction in the UK.

  • Making a big splash

    Whether you are treating heart disease or sexual dysfunction, the biggest competitor we face is often doing nothing.

  • It's all in the detail

    Defined by specific diseases, eg, psoriasis, rheumatoid arthritis, erectile dysfunction, etc, these groups will often discuss the topic in an oblique way. ... For example, erectile dysfunction conversations are often around sexual self-confidence, which

  • Endo testosterone gel approved

    Hypogonadism, or low testosterone, can lead to erectile dysfunction, fatigue, regression of secondary sexual characteristics and osteoporosis.

More from news
Approximately 1 fully matching, plus 24 partially matching documents found.

Latest Intelligence

  • Deal Watch February 2017 Deal Watch February 2017

    Acquisition - business unit. 1, 045. EndoCeutics/ AMAG Pharmaceuticals. Intraros (prasterone), non-oestrogen product for postmenopausal atrophic vaginitis (FDA approved), female sexual dysfunction (phase III).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics